3,0
5 feb 2017
Huidige werknemer, minder dan 1 jaar
Cambridge, East of England, England
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great product and opportunity to help prevent morbidity and mortality of patients with CV disease. Company infrastructure us improving but a long way to go. Need better focus.
Minpunten
Politics getting in the way of launch plans. Company hires people with expertise, and then Senior Managers who have no experience in the disease area but have longevity start to interfere and try and control the approach in the wrong way.